In Reply

Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine-based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.

Detalles Bibliográficos
Autores principales: Brandi, Giovanni, Deserti, Marzia, Vasuri, Francesco, Farioli, Andrea, Degiovanni, Alessio, Palloni, Andrea, Frega, Giorgio, Barbera, Maria A., de Lorenzo, Stefania, Garajova, Ingrid, Di Marco, Mariacristina, Pinna, Antonio D., Cescon, Matteo, Cucchetti, Alessandro, Ercolani, Giorgio, D’Errico-Grigioni, Antonietta, Pantaleo, Maria A., Biasco, Guido, Tavolari, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153345/
https://www.ncbi.nlm.nih.gov/pubmed/27807301
http://dx.doi.org/10.1634/theoncologist.2016-0286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153345/
https://www.ncbi.nlm.nih.gov/pubmed/27807301
http://dx.doi.org/10.1634/theoncologist.2016-0286

Ejemplares similares